Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA mild reaction at the injection site is one of the most frequently reported experiences on Mounjaro, and most of the time it means very little. Redness, a small bump, or brief tenderness after injecting tirzepatide are common, usually settle within a few days, and are not a reason to stop treatment. That said, knowing what a normal local reaction looks like — and what would prompt a call to your prescriber — matters. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before treatment begins, and they remain your first port of call if anything gives you pause. The NHS tirzepatide information page confirms that injection site reactions are among the recognised side effects and, in most cases, do not require stopping the medicine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common worry our prescribers hear is that redness or a lump at the injection site means something has gone wrong, an allergy, a contaminated pen, or the wrong dose. The reality is more reassuring. Local skin responses are a recognised and expected feature of subcutaneous injections in general, not a signal that tirzepatide is harming you. The medicine is deposited just beneath the skin into fatty tissue, and the body's local immune response to that can produce temporary redness, mild itching, a firm little patch, or light bruising. These are recorded in the Mounjaro Summary of Product Characteristics and acknowledged by the NHS tirzepatide page as common side effects.
They tend to be most noticeable in the first weeks of treatment or shortly after a dose increase, when your technique is still settling. Most people find they fade within 48 to 72 hours. The reaction isn't a reason to skip your next dose, but it is a reason to look at your technique, which is covered below. If you're reading this after your very first injection and the site looks a little angry, that's a familiar story. It usually calms down.
Explore the broader picture of how to inject Mounjaro correctly if you want to check your approach from the beginning.
A few technique and storage habits account for a large share of preventable site irritation. The most common one is injecting into the same spot every week; fatty tissue needs time to recover, and repeated trauma to one small patch of skin is a reliable way to produce a persistent lump called lipohypertrophy. The fix is straightforward: rotate through your three available sites (abdomen, outer thigh, upper arm) and vary the exact spot within each area each time.
Temperature at injection is another factor worth understanding. Tirzepatide drawn straight from the refrigerator can sting more and cause a stronger local response; the recommendation is to let the pen sit at room temperature for a short while before use. If your pen lives in the fridge door alongside the milk, taking it out while the kettle boils gives it a few minutes to take the chill off. For the exact room-temperature window allowed before use, check your Patient Information Leaflet, the safe period differs from what you may read online, and your specific batch matters. Our guidance on injecting Mounjaro straight from the fridge covers this in more detail.
Other practical points: clean the skin with an alcohol swab and let it dry fully before injecting (wet skin can cause stinging); press the pen firmly and hold it steady for the full count; avoid injecting into broken skin, scarred tissue, or areas with recent bruising. Using a fresh needle each time matters too, changing the needle with every injection keeps the tip sharp and reduces micro-trauma to the skin.
Most injection site reactions are a nuisance rather than a danger. But some presentations sit outside the normal range and need prompt attention. The MHRA's Yellow Card scheme encourages patients to report unexpected or severe side effects (including skin reactions that feel out of proportion) and those reports help regulators monitor medicines across the whole population.
Contact your prescriber or GP if: the redness or swelling at the site spreads rather than shrinks over 24 to 48 hours; the skin feels hot, hard, or begins to look infected; you develop a deep painful nodule that doesn't resolve; or the reaction at the site is significantly worse than anything you experienced at lower doses. These findings on their own are unlikely to be emergencies, but they warrant a clinical eye and potentially a short break from that injection site.
Call 999 or go to A&E immediately if you develop hives or widespread rash, swelling of the face, lips, throat, or tongue, or any difficulty breathing after an injection. This picture suggests a systemic allergic reaction, which is a different and more serious event than a local skin response. Information about distinguishing a true allergic reaction from a local site reaction is worth reading before you need it. Our page on what a red Mounjaro injection site means also walks through the visual signs that fall in and out of normal range.
If site reactions are consistently troublesome despite good technique, a conversation with your prescriber is the right move, not silent persistence. They may look at your injection approach, consider whether the current dose is progressing at the right pace, or document the reaction as part of your ongoing clinical record. Reactions can occasionally point to something worth investigating, such as a sensitivity to a component of the formulation, and that's a clinical assessment rather than something to manage alone.
It's also worth knowing that a reaction to the injection site is distinct from a systemic reaction to the medicine itself. Nausea, fatigue and GI effects are separate to what's happening at your skin. For a full picture of how tirzepatide is monitored and assessed for each patient, our Mounjaro overview covers the broader clinical profile. And if you have questions about the cost or process of ongoing private treatment, Mounjaro pricing at nume, sorry, at nume
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.